{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T09:18:07Z","timestamp":1787735887470,"version":"build-2784847793"},"reference-count":44,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Adium Pharma"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Objectives: Our primary objective was to compare the 12-month efficacy of two dosing regimens of intra-articular sodium hyaluronate (SH) in patients with knee osteoarthritis (OA) using a cross-study analysis within a non-inferiority framework. Methods: This study combined individual patient data from two prospective multicenter trials with similar outcome measures: the Trueba Davalillo study (five injections of 1% SH) and the SOYA Trial (single injection of 2% SH, with the possibility of retreatment after 6 months). The primary endpoint of this cross-study analysis was the relative change in pain intensity on a 100 mm visual analog scale (VAS) from baseline to 12 months. Secondary outcomes included changes in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and the proportion of patients achieving the Minimal Clinically Important Improvement (MCII). Non-inferiority was defined for the primary endpoint as the lower bound of the 95% confidence interval for the between-group difference remaining above \u22128%. Results: The modified intention-to-treat (mITT) population included 97 patients in the 1% SH group and 98 in the 2% SH group. At 12 months, the mean relative reduction in pain intensity was 33.61% for 1% SH and 37.67% for 2% SH (mean difference: 4.06%; 95% CI: \u22126.37% to 14.50%), compatible with non-inferiority (per the predefined \u22128% criterion) in this exploratory cross-trial analysis. No significant between-group differences were found in adjusted analyses for pain or WOMAC scores at 12 months. At 12 months, MCII responder rates were higher in the 1% SH group. Conclusions: This exploratory cross-trial analysis found results compatible with non-inferiority of 2% SH relative to 1% SH in improving pain and physical function over 12 months in patients with knee OA.<\/jats:p>","DOI":"10.3390\/jcm15176571","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T08:11:15Z","timestamp":1787731875000},"page":"6571","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploratory Cross-Trial Non-Inferiority Analysis of 2% Versus 1% Sodium Hyaluronate in Knee Osteoarthritis"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-2469-8388","authenticated-orcid":false,"given":"Fernando","family":"Costa","sequence":"first","affiliation":[{"name":"Corporate Clinical Studies Department, Adium Pharma, Ciudad Aut\u00f3noma de Buenos Aires B1603APO, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6145-0310","authenticated-orcid":false,"given":"Pilar Coronel","family":"Granado","sequence":"additional","affiliation":[{"name":"Scientific Department, Meiji Pharma Spain, Alcal\u00e1 de Henares, 28802 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Casas","sequence":"additional","affiliation":[{"name":"CR-Biostatistics, Evidenze Clinical Research, 28109 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego Maisonave","family":"Berdasco","sequence":"additional","affiliation":[{"name":"Scientific Advisory and Medical Writing Department, Evidenze Clinical Research, 28109 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1338-9911","authenticated-orcid":false,"given":"D\u00e9bora Renz Barreto","family":"Vianna","sequence":"additional","affiliation":[{"name":"Corporate Clinical Studies Department, Adium Pharma, Ciudad Aut\u00f3noma de Buenos Aires B1603APO, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.joca.2023.06.005","article-title":"Fundamentals of Osteoarthritis: Inflammatory Mediators in Osteoarthritis","volume":"31","author":"Monteagudo","year":"2023","journal-title":"Osteoarthr. Cartil."},{"key":"ref_2","unstructured":"GBD 2021 Osteoarthritis Collaborators (2023). Global, Regional, and National Burden of Osteoarthritis, 1990\u20132020 and Projections to 2050: A Systematic Analysis for the Global Burden of Disease Study 2021. Lancet Rheumatol., 5, e508\u2013e522."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1759720X241273009","DOI":"10.1177\/1759720X241273009","article-title":"Knee Osteoarthritis: Disease Burden, Available Treatments, and Emerging Options","volume":"16","author":"Langworthy","year":"2024","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/art.42089","article-title":"Prevalence Trends of Site-Specific Osteoarthritis From 1990 to 2019: Findings From the Global Burden of Disease Study 2019","volume":"74","author":"Long","year":"2022","journal-title":"Arthritis Rheumatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/art.24021","article-title":"Lifetime Risk of Symptomatic Knee Osteoarthritis","volume":"59","author":"Murphy","year":"2008","journal-title":"Arthritis Care Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"100587","DOI":"10.1016\/j.eclinm.2020.100587","article-title":"Global, Regional Prevalence, Incidence and Risk Factors of Knee Osteoarthritis in Population-Based Studies","volume":"29\u201330","author":"Cui","year":"2020","journal-title":"EClinicalMedicine"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41413-022-00226-9","article-title":"Current Understanding of Osteoarthritis Pathogenesis and Relevant New Approaches","volume":"10","author":"Tong","year":"2022","journal-title":"Bone Res."},{"key":"ref_8","first-page":"394","article-title":"Toe-In during Sit-To-Stand Reduces Knee Adduction Moment in People with Moderate Knee Osteoarthritis","volume":"13","author":"Faroughi","year":"2023","journal-title":"Muscles Ligaments Tendons J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.joca.2007.06.014","article-title":"OARSI Recommendations for the Management of Hip and Knee Osteoarthritis, Part I: Critical Appraisal of Existing Treatment Guidelines and Systematic Review of Current Research Evidence","volume":"15","author":"Zhang","year":"2007","journal-title":"Osteoarthr. Cartil."},{"key":"ref_10","first-page":"67","article-title":"Postural Control Pre- and Post-Group Supervised Clinic Based Exercise or Home Based Exercise in Patients with Knee Osteoarthritis: A Randomized Clinical Trial","volume":"14","author":"Vaz","year":"2024","journal-title":"Muscles Ligaments Tendons J."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Coxib and Traditional NSAID Trialists\u2019 (CNT) Collaboration, Bhala, N., Emberson, J., Merhi, A., Abramson, S., Arber, N., Baron, J.A., Bombardier, C., Cannon, C., and Farkouh, M.E. (2013). Vascular and Upper Gastrointestinal Effects of Non-Steroidal Anti-Inflammatory Drugs: Meta-Analyses of Individual Participant Data from Randomised Trials. Lancet, 382, 769\u2013779.","DOI":"10.1016\/S0140-6736(13)60900-9"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1136\/annrheumdis-2014-206914","article-title":"Paracetamol: Not as Safe as We Thought? A Systematic Literature Review of Observational Studies","volume":"75","author":"Roberts","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jbspin.2006.10.009","article-title":"Systemic Effects of Epidural and Intra-Articular Glucocorticoid Injections in Diabetic and Non-Diabetic Patients","volume":"74","author":"Younes","year":"2007","journal-title":"Jt. Bone Spine"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.2106\/JBJS.RVW.O.00029","article-title":"Blood Glucose Levels Following Intra-Articular Steroid Injections in Patients with Diabetes: A Systematic Review","volume":"4","author":"Choudhry","year":"2016","journal-title":"JBJS Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.semarthrit.2018.06.002","article-title":"Why We Should Definitely Include Intra-Articular Hyaluronic Acid as a Therapeutic Option in the Management of Knee Osteoarthritis: Results of an Extensive Critical Literature Review","volume":"48","author":"Maheu","year":"2019","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/acr.23204","article-title":"Use of Intraarticular Hyaluronic Acid in the Management of Knee Osteoarthritis in Clinical Practice","volume":"69","author":"Cooper","year":"2017","journal-title":"Arthritis Care Res."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Altman, R., Manjoo, A., Fierlinger, A., Niazi, F., and Nicholls, M. (2015). The Mechanism of Action for Hyaluronic Acid Treatment in the Osteoarthritic Knee: A Systematic Review. BMC Musculoskelet. Disord., 16.","DOI":"10.1186\/s12891-015-0775-z"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"155103","DOI":"10.52965\/001c.155103","article-title":"Advances in Hyaluronic Acid Therapy for Knee Osteoarthritis: Monotherapy and Combination Strategies: An Evidenced Based Review","volume":"18","author":"Cao","year":"2026","journal-title":"Orthop. Rev."},{"key":"ref_19","first-page":"9","article-title":"Clinical Efficacy of Intra-Articular Injections in Knee Osteoarthritis: A Prospective Randomized Study Comparing Hyaluronic Acid and Betamethasone","volume":"7","year":"2015","journal-title":"Open Access Rheumatol. Res. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.2147\/JPR.S321841","article-title":"One-Year, Efficacy and Safety Open Label Study, with a Single Injection of a New Hyaluronan for Knee OA: The SOYA Trial","volume":"14","author":"Blanco","year":"2021","journal-title":"J. Pain Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1001\/jama.2012.87802","article-title":"CONSORT Group Reporting of Noninferiority and Equivalence Randomized Trials: Extension of the CONSORT 2010 Statement","volume":"308","author":"Piaggio","year":"2012","journal-title":"JAMA"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1136\/ard.2011.152017","article-title":"A 40-Month Multicentre, Randomised Placebo-Controlled Study to Assess the Efficacy and Carry-over Effect of Repeated Intra-Articular Injections of Hyaluronic Acid in Knee Osteoarthritis: The AMELIA Project","volume":"70","author":"Coronel","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"ref_23","first-page":"253","article-title":"Concentrated Hyaluronic Acid Intraarticular Injection Is Well Tolerated by Osteoarthritic Joint and Prevents Pro-Inflammatory Mechanisms in the Osteoarthritic Synovium","volume":"30","author":"Largo","year":"2019","journal-title":"Osteoporos. Int."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S1063-4584(03)00082-7","article-title":"Response Relationship of VAS and Likert Scales in Osteoarthritis Efficacy Measurement","volume":"11","author":"Bolognese","year":"2003","journal-title":"Osteoarthr. Cartil."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1002\/acr.21747","article-title":"Minimum Clinically Important Improvement and Patient Acceptable Symptom State in Pain and Function in Rheumatoid Arthritis, Ankylosing Spondylitis, Chronic Back Pain, Hand Osteoarthritis, and Hip and Knee Osteoarthritis: Results from a Prospective Multinational Study","volume":"64","author":"Tubach","year":"2012","journal-title":"Arthritis Care Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1111\/bcp.13280","article-title":"Defining the Noninferiority Margin and Analysing Noninferiority: An Overview","volume":"83","author":"Althunian","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13075-015-0557-x","article-title":"Comparison of Two Hyaluronic Acid Formulations for Safety and Efficacy (CHASE) Study in Knee Osteoarthritis: A Multicenter, Randomized, Double-Blind, 26-Week Non-Inferiority Trial Comparing Durolane to Artz","volume":"17","author":"Zhang","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1007\/s12325-021-01648-3","article-title":"Non-Inferiority of a Single Injection of Sodium Hyaluronate Plus Sorbitol to Hylan G-F20: A 6-Month Randomized Controlled Trial","volume":"38","author":"Cortet","year":"2021","journal-title":"Adv. Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.joca.2011.07.016","article-title":"Efficacy Evaluation of Highly Purified Intra-Articular Hyaluronic Acid (Sinovial(\u00ae)) vs Hylan G-F20 (Synvisc(\u00ae)) in the Treatment of Symptomatic Knee Osteoarthritis. A Double-Blind, Controlled, Randomized, Parallel-Group Non-Inferiority Study","volume":"19","author":"Pavelka","year":"2011","journal-title":"Osteoarthr. Cartil."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e41335","DOI":"10.1097\/MD.0000000000041335","article-title":"Recent Advances in Osteoarthritis Research: A Review of Treatment Strategies, Mechanistic Insights, and Acupuncture","volume":"104","author":"Lou","year":"2025","journal-title":"Medicine"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1038\/s41416-022-01937-w","article-title":"Interpreting the Results of Noninferiority Trials-a Review","volume":"127","author":"Cuzick","year":"2022","journal-title":"Br. J. Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4103\/0253-7613.83103","article-title":"Non-Inferiority Clinical Trials: Practical Issues and Current Regulatory Perspective","volume":"43","author":"Gupta","year":"2011","journal-title":"Indian J. Pharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jval.2011.04.002","article-title":"Interpreting Indirect Treatment Comparisons and Network Meta-Analysis for Health-Care Decision Making: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 1","volume":"14","author":"Jansen","year":"2011","journal-title":"Value Health"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3899\/jrheum.141150","article-title":"Minimal Clinically Important Difference as Applied in Rheumatology: An OMERACT Rasch Working Group Systematic Review and Critique","volume":"43","author":"Leung","year":"2016","journal-title":"J. Rheumatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1177\/03635465231152484","article-title":"The Minimal Clinically Important Difference Changes Greatly Based on the Different Calculation Methods","volume":"51","author":"Franceschini","year":"2023","journal-title":"Am. J. Sports Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/MRR.0000000000000613","article-title":"Challenges in Applying Minimal Clinically Important Difference: A Critical Review","volume":"47","author":"Podurgiel","year":"2024","journal-title":"Int. J. Rehabil. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2309499019895029","DOI":"10.1177\/2309499019895029","article-title":"One-Year Follow-up of Efficacy and Cost of Repeated Doses versus Single Larger Dose of Intra-Articular Hyaluronic Acid for Knee Osteoarthritis","volume":"28","author":"Suppan","year":"2020","journal-title":"J. Orthop. Surg."},{"key":"ref_38","first-page":"25549","article-title":"A Comprehensive Review of Viscosupplementation in Osteoarthritis of the Knee","volume":"13","author":"Peck","year":"2025","journal-title":"Orthop. Rev."},{"key":"ref_39","first-page":"247","article-title":"Effect of Mechanical Traction and Therapeutic Exercises in Treatment of Primary Knee Osteoarthritis","volume":"14","author":"Riyad","year":"2024","journal-title":"Muscles Ligaments Tendons J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.joca.2016.07.010","article-title":"Comparative Safety Profile of Hyaluronic Acid Products for Knee Osteoarthritis: A Systematic Review and Network Meta-Analysis","volume":"24","author":"Bannuru","year":"2016","journal-title":"Osteoarthr. Cartil."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e033334","DOI":"10.1136\/bmjopen-2019-033334","article-title":"Existing Comorbidities in People with Osteoarthritis: A Retrospective Analysis of a Population-Based Cohort in Alberta, Canada","volume":"9","author":"Marshall","year":"2019","journal-title":"BMJ Open"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"100061","DOI":"10.1016\/j.cgpj.2025.100061","article-title":"Comorbidity Profiles and Treatment Patterns of Osteoarthritis Patients in Beijing: A Cross-Sectional Study Based on Community Medical Records","volume":"2","author":"Zheng","year":"2025","journal-title":"Chin. Gen. Pract. J."},{"key":"ref_43","first-page":"1833","article-title":"Validation Study of WOMAC: A Health Status Instrument for Measuring Clinically Important Patient Relevant Outcomes to Antirheumatic Drug Therapy in Patients with Osteoarthritis of the Hip or Knee","volume":"15","author":"Bellamy","year":"1988","journal-title":"J. Rheumatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/bmb\/ldac029","article-title":"Knee Osteoarthritis, Joint Laxity and PROMs Following Conservative Management versus Surgical Reconstruction for ACL Rupture: A Meta-Analysis","volume":"145","author":"Migliorini","year":"2023","journal-title":"Br. Med. Bull."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/17\/6571\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T08:26:40Z","timestamp":1787732800000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/17\/6571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":44,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["jcm15176571"],"URL":"https:\/\/doi.org\/10.3390\/jcm15176571","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]}}}